TAMPA, FL - May 5, 2009 - Clinical Pharmacology, the award-winning drug information and medication management reference from Gold Standard/ELSEVIER, has been updated online with the latest recommendations from the federal Centers for Disease Control (CDC) regarding the treatment of the Swine Influenza A (H1N1) Virus.

The Clinical Pharmacology editorial team continues to monitor the CDC and other federal and state health agencies for additional updates.

“Clinical Pharmacology is committed to providing its users with timely and critical information that affects how patients are treated,” said Kathy Vieson, Vice President and Director of Clinical References for Gold Standard/ELSEVIER. “Having access to the most up-to-date drug and medication reference available helps pharmacists provide fast, accurate and understandable answers to patients’ questions and concerns.”

Clinical Pharmacology has provided a new resource section on its subscribers-only Web site home page providing links to the current CDC, Food & Drug Administration and World Health Organization Web sites regarding the Swine Flu pandemic.

Clinical Pharmacology has also posted a guide for pharmacists regarding pandemic flu preparedness created by the NACDS (National Association of Chain Drug Stores) Foundation, the American Pharmacists Association and the American Society of Health-System Pharmacists.

In addition, Clinical Pharmacology monographs for Oseltamivir (Tamiflu) and Zanamivir (Relenza) were updated within 24 hours of the information being posted to the CDC Web site, and continue to be updated in real time as further information becomes available.


###

About Gold Standard/ELSEVIER
Based in Tampa, Fla., Gold Standard/ELSEVIER is a leading developer of drug information databases, software and clinical information solutions. The Company’s products are developed by a staff of highly trained professionals with extensive experience in pharmacy practice, electronic publishing and software development. Customers include more than 1,000 hospitals, the nation’s largest retail pharmacy chains and consultant pharmacy organizations, state and federal agencies, the country’s top pharmacy and medical schools, leading health information web sites, and hundreds of thousands of healthcare professionals and consumers worldwide. To learn more about Gold Standard/ELSEVIER, visit www.goldstandard.com or call (800) 375-0943.

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).